Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Jian Sheng Loh,Wen Qi Mak,Li Kar Stella Tan,Chu Xin Ng,Hong Hao Chan,Shiau Hueh Yeow,Jhi Biau Foo,Yong Sze Ong,Chee Wun How,Kooi Yeong Khaw

DOI: https://doi.org/10.1038/s41392-024-01743-1

IF: 39.3

2024-02-17

Signal Transduction and Targeted Therapy

Abstract:The human gastrointestinal tract is populated with a diverse microbial community. The vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect of human biology, including health maintenance, development, aging, and disease. The advent of new sequencing technologies and culture-independent methods has allowed researchers to move beyond correlative studies toward mechanistic explorations to shed light on microbiome–host interactions. Evidence has unveiled the bidirectional communication between the gut microbiome and the central nervous system, referred to as the "microbiota–gut–brain axis". The microbiota–gut–brain axis represents an important regulator of glial functions, making it an actionable target to ameliorate the development and progression of neurodegenerative diseases. In this review, we discuss the mechanisms of the microbiota–gut–brain axis in neurodegenerative diseases. As the gut microbiome provides essential cues to microglia, astrocytes, and oligodendrocytes, we examine the communications between gut microbiota and these glial cells during healthy states and neurodegenerative diseases. Subsequently, we discuss the mechanisms of the microbiota–gut–brain axis in neurodegenerative diseases using a metabolite-centric approach, while also examining the role of gut microbiota-related neurotransmitters and gut hormones. Next, we examine the potential of targeting the intestinal barrier, blood–brain barrier, meninges, and peripheral immune system to counteract glial dysfunction in neurodegeneration. Finally, we conclude by assessing the pre-clinical and clinical evidence of probiotics, prebiotics, and fecal microbiota transplantation in neurodegenerative diseases. A thorough comprehension of the microbiota–gut–brain axis will foster the development of effective therapeutic interventions for the management of neurodegenerative diseases.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The paper primarily explores the mechanisms and therapeutic applications of the microbiota-gut-brain axis in neurodegenerative diseases. Specifically, the paper focuses on the following aspects:

1. **Mechanisms of the Microbiota-Gut-Brain Axis**: The paper discusses in detail the bidirectional communication mechanisms between the gut microbiota and the central nervous system, including the roles of the immune system, vagus nerve, enteric nervous system, neuroendocrine system, and circulatory system.

2. **Interactions Between Microbiota and Glial Cells**: The gut microbiota influences the functions of microglia, astrocytes, and oligodendrocytes through various pathways, playing a crucial role in both healthy states and neurodegenerative diseases.

3. **Roles of Metabolites, Neurotransmitters, and Hormones**: The paper explores how metabolites, neurotransmitters, and hormones produced by the gut microbiota are involved in the pathological processes of neurodegenerative diseases.

4. **Targeted Therapeutic Strategies**: The authors also discuss the potential to improve glial cell function and combat neurodegeneration by regulating the gut barrier, blood-brain barrier, meninges, and peripheral immune system.

5. **Clinical Evidence**: Finally, the paper evaluates the preclinical and clinical evidence of probiotics, prebiotics, and fecal microbiota transplantation in neurodegenerative diseases.

In summary, this review aims to update the current research on the mechanisms of the microbiota-gut-brain axis in neurodegenerative diseases and propose potential therapeutic interventions.